SEARCH RESULT

Total Matching Records found : 29

WTO talks set for revival as India nears deal with US, EU -Sidhartha & Surojit Gupta

-The Times of India NEW DELHI: After being in deep freeze for over three months, a global trade deal is finally in sight with the US and the European Union showing signs of accepting India's demand for providing flexibility to developing countries in fixing minimum support price for farm products. In return, India will sign the stalled international treaty on easier customs rules once an agreement on the contentious food security...

More »

US to launch fresh review of India's patent regime -Sidhartha

-The Times of India NEW DELHI: Within days of Prime Minister Narendra Modi's return from the US, the US Trade Representative (USTR) has launched a fresh offensive against India's intellectual property rights (IPR) regime, a move that may lead to the government going slow on a bilateral dialogue with Washington. On Tuesday, USTR will launch what it calls an "out-of-cycle review" (OCR) of India's IPR regime, following a report released earlier this...

More »

Has PM Modi bowed to US pressure on patent laws? -Rema Nagarajan

-The Times of India A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists across the world apprehensive that the Modi government might be bending to US pressure to change its patent laws. Several health policy experts and activists have issued statements urging India not to give in to US...

More »

India must call the US' bluff on patents-Arvind Panagariya

-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...

More »

Outside the patent monopolies -Ritu Kamal

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close